Home | Articles
Published on:February 2024
Indian Journal of Pharmaceutical Education and Research, 2024; 58(2):603-609
Original Article | doi:10.5530/ijper.58.2.67

Influence of Cirsimaritin on Anticancer Activity against HCT-116 Cell Line


Authors and affiliation (s):

Mohammed Ageeli Hakami

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al- Quwayiyah, Shaqra University, Riyadh, SAUDI ARABIA.

Abstract:

Background: Statistics show colon cancer is the third most severe cancer type worldwide. It was discovered that there is a very high death and morbidity rate. Along with breast, prostate, lung, and colon cancer is one of the most common tumors worldwide. Objectives: Natural products have drawn interest in recent years for preventing cancer. This is due to their numerous health advantages, apparent lack of toxicity and side effects, and the limits of chemotherapeutic medicines. Numerous studies have shown that natural products have a wide range of biological effects. Materials and Methods: A flavonoid class phytochemical known as cirsimaritin, also known as 4',5-dihydroxy-6,7-dimethoxyflavone, has been discovered in the medicinal plant. The current investigation was the determination of cell proliferative XTT assay, AO/EtBr, intracellular oxygen species, Oxidative Stress Markers, and Cell cycle analysis using flow cytometry by PI analysis. Results: HCT-116 cells' cell viability was reduced with an increased concentration of cirsimaritin. ROS and apoptosis were increased with an elevated cirsimaritin concentration. Conclusion: All these results suggest that cirsimaritin can be used as a potent anticancer drug for colon cancer.

Keywords: Colon cancer, Cirsimaritin, Apoptosis, Cell viability, ROS.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs